GRN and colorectal carcinoma: Moreover, as recent reports indicate a role for progranulin in boosting epithelial–mesenchymal transition, migration, and invasion of CRC cells (Ding et al., 2018; Zhao et al., 2018), approaches aimed at targeting progranulin could further benefit patients with advanced stages of the disease.